Click for best price
Opioids Agonist Drugs Market Size, Share 2023
Opioid drugs act on the opioid receptors present in the central and peripheral nervous system. The drug class primarily used in relieving pain includes natural, semi-synthetic, and synthetic opioids.Opioids can be administered as oral pills, parenteral, liquids, patches, or lozenges.
This report aims to provide a comprehensive presentation of the global market for Opioids Agonist Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioids Agonist Drugs. This report contains market size and forecasts of Opioids Agonist Drugs in global, including the following market information:
Global Opioids Agonist Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Opioids Agonist Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Opioids Agonist Drugs companies in 2022 (%)
The global Opioids Agonist Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Legalizing Cannabis to Impact Opioids Agonist Drugs Market Growth
We surveyed the Opioids Agonist Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Opioids Agonist Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Opioids Agonist Drugs Market Segment Percentages, by Type, 2022 (%)
Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Global Opioids Agonist Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Opioids Agonist Drugs Market Segment Percentages, by Application, 2022 (%)
Pain Management
Cough Treatment
Diarrhea Treatment
Global Opioids Agonist Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Opioids Agonist Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Opioids Agonist Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Opioids Agonist Drugs revenues share in global market, 2022 (%)
Key companies Opioids Agonist Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Opioids Agonist Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Purdue Pharma
Titan pharmaceuticals
Boehringer Ingelheim
Janssen Pharmaceuticals, Inc
Sanofi
Sun Pharmaceuticals
Mallinckrodt Pharmaceuticals
Egalet Corporation
Endo Pharmaceuticals Inc.
Allergan, Plc
Pfizer Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Opioids Agonist Drugs, market overview.
Chapter 2: Global Opioids Agonist Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Opioids Agonist Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Opioids Agonist Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Opioids Agonist Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Opioids Agonist Drugs Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
72 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Opioids Agonist Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Opioids Agonist Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Opioids Agonist Drugs Overall Market Size
2.1 Global Opioids Agonist Drugs Market Size: 2022 VS 2029
2.2 Global Opioids Agonist Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Opioids Agonist Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Opioids Agonist Drugs Players in Global Market
3.2 Top Global Opioids Agonist Drugs Companies Ranked by Revenue
3.3 Global Opioids Agonist Drugs Revenue by Companies
3.4 Global Opioids Agonist Drugs Sales by Companies
3.5 Global Opioids Agonist Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Opioids Agonist Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Opioids Agonist Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Opioids Agonist Drugs Players in Global Market
3.8.1 List of Global Tier 1 Opioids Agonist Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Opioids Agonist Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Opioids Agonist Drugs Market Size Markets, 2022 & 2029
4.1.2 Codeine
4.1.3 Fentanyl
4.1.4 Meperidine
4.1.5 Methadone
4.1.6 Morphine
4.1.7 Hydrocodone
4.2 By Type - Global Opioids Agonist Drugs Revenue & Forecasts
4.2.1 By Type - Global Opioids Agonist Drugs Revenue, 2018-2023
4.2.2 By Type - Global Opioids Agonist Drugs Revenue, 2024-2029
4.2.3 By Type - Global Opioids Agonist Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Opioids Agonist Drugs Sales & Forecasts
4.3.1 By Type - Global Opioids Agonist Drugs Sales, 2018-2023
4.3.2 By Type - Global Opioids Agonist Drugs Sales, 2024-2029
4.3.3 By Type - Global Opioids Agonist Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Opioids Agonist Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Opioids Agonist Drugs Market Size, 2022 & 2029
5.1.2 Pain Management
5.1.3 Cough Treatment
5.1.4 Diarrhea Treatment
5.2 By Application - Global Opioids Agonist Drugs Revenue & Forecasts
5.2.1 By Application - Global Opioids Agonist Drugs Revenue, 2018-2023
5.2.2 By Application - Global Opioids Agonist Drugs Revenue, 2024-2029
5.2.3 By Application - Global Opioids Agonist Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Opioids Agonist Drugs Sales & Forecasts
5.3.1 By Application - Global Opioids Agonist Drugs Sales, 2018-2023
5.3.2 By Application - Global Opioids Agonist Drugs Sales, 2024-2029
5.3.3 By Application - Global Opioids Agonist Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Opioids Agonist Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Opioids Agonist Drugs Market Size, 2022 & 2029
6.2 By Region - Global Opioids Agonist Drugs Revenue & Forecasts
6.2.1 By Region - Global Opioids Agonist Drugs Revenue, 2018-2023
6.2.2 By Region - Global Opioids Agonist Drugs Revenue, 2024-2029
6.2.3 By Region - Global Opioids Agonist Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Opioids Agonist Drugs Sales & Forecasts
6.3.1 By Region - Global Opioids Agonist Drugs Sales, 2018-2023
6.3.2 By Region - Global Opioids Agonist Drugs Sales, 2024-2029
6.3.3 By Region - Global Opioids Agonist Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Opioids Agonist Drugs Revenue, 2018-2029
6.4.2 By Country - North America Opioids Agonist Drugs Sales, 2018-2029
6.4.3 US Opioids Agonist Drugs Market Size, 2018-2029
6.4.4 Canada Opioids Agonist Drugs Market Size, 2018-2029
6.4.5 Mexico Opioids Agonist Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Opioids Agonist Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Opioids Agonist Drugs Sales, 2018-2029
6.5.3 Germany Opioids Agonist Drugs Market Size, 2018-2029
6.5.4 France Opioids Agonist Drugs Market Size, 2018-2029
6.5.5 U.K. Opioids Agonist Drugs Market Size, 2018-2029
6.5.6 Italy Opioids Agonist Drugs Market Size, 2018-2029
6.5.7 Russia Opioids Agonist Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Opioids Agonist Drugs Market Size, 2018-2029
6.5.9 Benelux Opioids Agonist Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Opioids Agonist Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Opioids Agonist Drugs Sales, 2018-2029
6.6.3 China Opioids Agonist Drugs Market Size, 2018-2029
6.6.4 Japan Opioids Agonist Drugs Market Size, 2018-2029
6.6.5 South Korea Opioids Agonist Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Opioids Agonist Drugs Market Size, 2018-2029
6.6.7 India Opioids Agonist Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Opioids Agonist Drugs Revenue, 2018-2029
6.7.2 By Country - South America Opioids Agonist Drugs Sales, 2018-2029
6.7.3 Brazil Opioids Agonist Drugs Market Size, 2018-2029
6.7.4 Argentina Opioids Agonist Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Opioids Agonist Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Opioids Agonist Drugs Sales, 2018-2029
6.8.3 Turkey Opioids Agonist Drugs Market Size, 2018-2029
6.8.4 Israel Opioids Agonist Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Opioids Agonist Drugs Market Size, 2018-2029
6.8.6 UAE Opioids Agonist Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Purdue Pharma
7.1.1 Purdue Pharma Company Summary
7.1.2 Purdue Pharma Business Overview
7.1.3 Purdue Pharma Opioids Agonist Drugs Major Product Offerings
7.1.4 Purdue Pharma Opioids Agonist Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Purdue Pharma Key News & Latest Developments
7.2 Titan pharmaceuticals
7.2.1 Titan pharmaceuticals Company Summary
7.2.2 Titan pharmaceuticals Business Overview
7.2.3 Titan pharmaceuticals Opioids Agonist Drugs Major Product Offerings
7.2.4 Titan pharmaceuticals Opioids Agonist Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Titan pharmaceuticals Key News & Latest Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Opioids Agonist Drugs Major Product Offerings
7.3.4 Boehringer Ingelheim Opioids Agonist Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Boehringer Ingelheim Key News & Latest Developments
7.4 Janssen Pharmaceuticals, Inc
7.4.1 Janssen Pharmaceuticals, Inc Company Summary
7.4.2 Janssen Pharmaceuticals, Inc Business Overview
7.4.3 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Major Product Offerings
7.4.4 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Janssen Pharmaceuticals, Inc Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Opioids Agonist Drugs Major Product Offerings
7.5.4 Sanofi Opioids Agonist Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Sanofi Key News & Latest Developments
7.6 Sun Pharmaceuticals
7.6.1 Sun Pharmaceuticals Company Summary
7.6.2 Sun Pharmaceuticals Business Overview
7.6.3 Sun Pharmaceuticals Opioids Agonist Drugs Major Product Offerings
7.6.4 Sun Pharmaceuticals Opioids Agonist Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Sun Pharmaceuticals Key News & Latest Developments
7.7 Mallinckrodt Pharmaceuticals
7.7.1 Mallinckrodt Pharmaceuticals Company Summary
7.7.2 Mallinckrodt Pharmaceuticals Business Overview
7.7.3 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Major Product Offerings
7.7.4 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Mallinckrodt Pharmaceuticals Key News & Latest Developments
7.8 Egalet Corporation
7.8.1 Egalet Corporation Company Summary
7.8.2 Egalet Corporation Business Overview
7.8.3 Egalet Corporation Opioids Agonist Drugs Major Product Offerings
7.8.4 Egalet Corporation Opioids Agonist Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Egalet Corporation Key News & Latest Developments
7.9 Endo Pharmaceuticals Inc.
7.9.1 Endo Pharmaceuticals Inc. Company Summary
7.9.2 Endo Pharmaceuticals Inc. Business Overview
7.9.3 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Major Product Offerings
7.9.4 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Endo Pharmaceuticals Inc. Key News & Latest Developments
7.10 Allergan, Plc
7.10.1 Allergan, Plc Company Summary
7.10.2 Allergan, Plc Business Overview
7.10.3 Allergan, Plc Opioids Agonist Drugs Major Product Offerings
7.10.4 Allergan, Plc Opioids Agonist Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Allergan, Plc Key News & Latest Developments
7.11 Pfizer Inc
7.11.1 Pfizer Inc Company Summary
7.11.2 Pfizer Inc Opioids Agonist Drugs Business Overview
7.11.3 Pfizer Inc Opioids Agonist Drugs Major Product Offerings
7.11.4 Pfizer Inc Opioids Agonist Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Pfizer Inc Key News & Latest Developments
8 Global Opioids Agonist Drugs Production Capacity, Analysis
8.1 Global Opioids Agonist Drugs Production Capacity, 2018-2029
8.2 Opioids Agonist Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Opioids Agonist Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Opioids Agonist Drugs Supply Chain Analysis
10.1 Opioids Agonist Drugs Industry Value Chain
10.2 Opioids Agonist Drugs Upstream Market
10.3 Opioids Agonist Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Opioids Agonist Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Opioids Agonist Drugs in Global Market
Table 2. Top Opioids Agonist Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Opioids Agonist Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Opioids Agonist Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Opioids Agonist Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Opioids Agonist Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Opioids Agonist Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Opioids Agonist Drugs Product Type
Table 9. List of Global Tier 1 Opioids Agonist Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Opioids Agonist Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Opioids Agonist Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Opioids Agonist Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Opioids Agonist Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Opioids Agonist Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Opioids Agonist Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Opioids Agonist Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Opioids Agonist Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Opioids Agonist Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Opioids Agonist Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Opioids Agonist Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Opioids Agonist Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Opioids Agonist Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Opioids Agonist Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Opioids Agonist Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Opioids Agonist Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Opioids Agonist Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Opioids Agonist Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Opioids Agonist Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Opioids Agonist Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Opioids Agonist Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Opioids Agonist Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Opioids Agonist Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Opioids Agonist Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Opioids Agonist Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Opioids Agonist Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Opioids Agonist Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Opioids Agonist Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Opioids Agonist Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Opioids Agonist Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Opioids Agonist Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Opioids Agonist Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Opioids Agonist Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Opioids Agonist Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Opioids Agonist Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Opioids Agonist Drugs Sales, (K Units), 2024-2029
Table 46. Purdue Pharma Company Summary
Table 47. Purdue Pharma Opioids Agonist Drugs Product Offerings
Table 48. Purdue Pharma Opioids Agonist Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Purdue Pharma Key News & Latest Developments
Table 50. Titan pharmaceuticals Company Summary
Table 51. Titan pharmaceuticals Opioids Agonist Drugs Product Offerings
Table 52. Titan pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Titan pharmaceuticals Key News & Latest Developments
Table 54. Boehringer Ingelheim Company Summary
Table 55. Boehringer Ingelheim Opioids Agonist Drugs Product Offerings
Table 56. Boehringer Ingelheim Opioids Agonist Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Boehringer Ingelheim Key News & Latest Developments
Table 58. Janssen Pharmaceuticals, Inc Company Summary
Table 59. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product Offerings
Table 60. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Janssen Pharmaceuticals, Inc Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi Opioids Agonist Drugs Product Offerings
Table 64. Sanofi Opioids Agonist Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Sanofi Key News & Latest Developments
Table 66. Sun Pharmaceuticals Company Summary
Table 67. Sun Pharmaceuticals Opioids Agonist Drugs Product Offerings
Table 68. Sun Pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Sun Pharmaceuticals Key News & Latest Developments
Table 70. Mallinckrodt Pharmaceuticals Company Summary
Table 71. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product Offerings
Table 72. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Mallinckrodt Pharmaceuticals Key News & Latest Developments
Table 74. Egalet Corporation Company Summary
Table 75. Egalet Corporation Opioids Agonist Drugs Product Offerings
Table 76. Egalet Corporation Opioids Agonist Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Egalet Corporation Key News & Latest Developments
Table 78. Endo Pharmaceuticals Inc. Company Summary
Table 79. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product Offerings
Table 80. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Endo Pharmaceuticals Inc. Key News & Latest Developments
Table 82. Allergan, Plc Company Summary
Table 83. Allergan, Plc Opioids Agonist Drugs Product Offerings
Table 84. Allergan, Plc Opioids Agonist Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Allergan, Plc Key News & Latest Developments
Table 86. Pfizer Inc Company Summary
Table 87. Pfizer Inc Opioids Agonist Drugs Product Offerings
Table 88. Pfizer Inc Opioids Agonist Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Pfizer Inc Key News & Latest Developments
Table 90. Opioids Agonist Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 91. Global Opioids Agonist Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Opioids Agonist Drugs Production by Region, 2018-2023 (K Units)
Table 93. Global Opioids Agonist Drugs Production by Region, 2024-2029 (K Units)
Table 94. Opioids Agonist Drugs Market Opportunities & Trends in Global Market
Table 95. Opioids Agonist Drugs Market Drivers in Global Market
Table 96. Opioids Agonist Drugs Market Restraints in Global Market
Table 97. Opioids Agonist Drugs Raw Materials
Table 98. Opioids Agonist Drugs Raw Materials Suppliers in Global Market
Table 99. Typical Opioids Agonist Drugs Downstream
Table 100. Opioids Agonist Drugs Downstream Clients in Global Market
Table 101. Opioids Agonist Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Opioids Agonist Drugs Segment by Type in 2022
Figure 2. Opioids Agonist Drugs Segment by Application in 2022
Figure 3. Global Opioids Agonist Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Opioids Agonist Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Opioids Agonist Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Opioids Agonist Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Opioids Agonist Drugs Revenue in 2022
Figure 9. By Type - Global Opioids Agonist Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Opioids Agonist Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Opioids Agonist Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Opioids Agonist Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Opioids Agonist Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Opioids Agonist Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Opioids Agonist Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Opioids Agonist Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Opioids Agonist Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Opioids Agonist Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Opioids Agonist Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Opioids Agonist Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Opioids Agonist Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Opioids Agonist Drugs Sales Market Share, 2018-2029
Figure 23. US Opioids Agonist Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Opioids Agonist Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Opioids Agonist Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Opioids Agonist Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Opioids Agonist Drugs Sales Market Share, 2018-2029
Figure 28. Germany Opioids Agonist Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Opioids Agonist Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Opioids Agonist Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Opioids Agonist Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Opioids Agonist Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Opioids Agonist Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Opioids Agonist Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Opioids Agonist Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Opioids Agonist Drugs Sales Market Share, 2018-2029
Figure 37. China Opioids Agonist Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Opioids Agonist Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Opioids Agonist Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Opioids Agonist Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Opioids Agonist Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Opioids Agonist Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Opioids Agonist Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Opioids Agonist Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Opioids Agonist Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Opioids Agonist Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Opioids Agonist Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Opioids Agonist Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Opioids Agonist Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Opioids Agonist Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Opioids Agonist Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Opioids Agonist Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Opioids Agonist Drugs by Region, 2022 VS 2029
Figure 54. Opioids Agonist Drugs Industry Value Chain
Figure 55. Marketing Channels
